Live News Categoriesequity

Sanofi (SAN.PA) News

Follow Sanofi (SAN.PA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol SAN.PA Asset equity Sector Markets 90 days 1 Last 71.46 Updated Jul 08, 2026, 05:16 AM UTC Open live news feed Open SAN.PA chart & news

H AlphaValue/Baader Europe Cuts Sanofi Price Target After Scrapped Late-Stage Rare Neurological Disease Trial () -- AlphaValue/Baader Europe reduced its price target for Sanofi (SAN.PA) after the French drugmaker discontinued the late-stage clinical study of riliprubart in chronic inflammatory demyelinating polyneuropathy. "Had EARNINGS | Jul 08, 2026, 05:16 AM UTC